Open AccessPre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
Author(s) -
Sebastián Marciano,
Silvia Borzi,
Melisa Dirchwolf,
Ezequiel Ridruejo,
Manuel Mendizábal,
Fernando Bessone,
M.E. Sirotinsky,
Diego Giunta,
Julieta Trinks,
Pablo A. Olivera,
Omar Galdame,
Marcelo O. Silva,
Hugo Fainboim,
Adrián Gadano
Publication year - 2015
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v7.i4.703
Subject(s) - medicine , ribavirin , gastroenterology , hepatitis c virus , hepatitis c , genotype , fibrosis , steatosis , liver disease , immunology , virus , gene , biochemistry , chemistry
To evaluate pre-treatment factors associated with sustained virological response (SVR) in patients with hepatitis C virus (HCV) genotype 3 treated with peginterferon and ribavirin (RBV).